T
0.651
0.03 (5.40%)
Previous Close | 0.617 |
Open | 0.625 |
Volume | 15,398,258 |
Avg. Volume (3M) | 33,072,217 |
Market Cap | 714,593,792 |
Price / Sales | 1.59 |
Price / Book | 1.07 |
52 Weeks Range | |
Earnings Date | 9 Oct 2025 |
Profit Margin | -114.40% |
Operating Margin (TTM) | -16.76% |
Diluted EPS (TTM) | -1.10 |
Quarterly Revenue Growth (YOY) | -1.40% |
Total Debt/Equity (MRQ) | 12.73% |
Current Ratio (MRQ) | 2.62 |
Operating Cash Flow (TTM) | -51.09 M |
Levered Free Cash Flow (TTM) | 26.37 M |
Return on Assets (TTM) | -1.63% |
Return on Equity (TTM) | -30.73% |
Market Trend
Short Term | Medium Term | ||
Industry | Drug Manufacturers - Specialty & Generic (US) | Bullish | Mixed |
Drug Manufacturers - Specialty & Generic (Global) | Bullish | Mixed | |
Stock | Tilray Brands, Inc. | Bullish | Mixed |
AIStockmoo Score
0.0
Analyst Consensus | 1.5 |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | -1.5 |
Technical Oscillators | 2.0 |
Average | 0.00 |
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol. |
|
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Investment Style | Small Value |
% Held by Insiders | 0.69% |
% Held by Institutions | 10.10% |
52 Weeks Range | ||
Median | 2.00 (207.46%) | |
Total | 1 Buy |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Jefferies | 25 Aug 2025 | 2.00 (207.46%) | Buy | 1.39 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |